Parsippany, NJ – November 13, 2024 – Ferring Pharmaceuticals is grateful  to New Jersey and Minnesota for recognizing November as Clostridioides difficile (C. diff) Infection Awareness Month. This is the fifth year in a row that the offices of Governor Phil Murphy (New Jersey) and Governor Tim Walz (Minnesota) issued proclamations to help educate the public about the severity of […]

Real-world analyses evaluated the effectiveness of REBYOTA in patients with GI conditions or comorbidities as well as those who received therapy at home or in a clinic Interim data from a third analysis reported on changes in health-related quality of life  among REBYOTA patients Analyses add to growing body of real-world data for REBYOTA Parsippany, NJ – October 28, 2024 […]

Four abstracts, including two oral and two poster presentations, highlight Ferring’s dedication and multi-focus approach to advancing fertility care Parsippany, NJ – October 18, 2024 – Ferring Pharmaceuticals will present new data from four abstracts at the upcoming 2024 American Society for Reproductive Medicine (ASRM) Congress, being held October 19-23 in Denver, Colorado, and virtually. “We are pleased to share […]